User:Paektu41/sandbox

AO Nazionalnaja Immunobiologitscheskaja Kompanija
Company type	State Enterprise
Industry	Pharmaceutical holding
Founded	2013
Headquarters	Moscow, Russia
Products	Various pharmaceutical goods, specialises in drugs for infectious diseases
Owner	State corporation Rostec holds a 75% stake, with remainder owned by Marathon group
Website	www.nacimbio.ru

This is the user sandbox of Paektu41. A user sandbox is a subpage of the user's user page. It serves as a testing spot and page development space for the user and is not an encyclopedia article. Create or edit your own sandbox here.

Other sandboxes: Main sandbox | Template sandbox

Finished writing a draft article? Are you ready to request review of it by an experienced editor for possible inclusion in Wikipedia? Submit your draft for review!

Nacimbio (also wrote as Natsimbio), or OJSC National Immunobiological Company, is a subsidiary of the Rostec state corporation in Russia and was established in 2013 as apart of an effort by the Government of Russia to achieve independence in the production of pharmaceutical products, particularly those for the treatment of communicable diseases. ^[1]

Ownership

Nacimbio is a state owned enterprise in Russia, with Rostec holding a 75% stake in the company, with the remaining 25% stake owned by Russian investment firm Marathon group.

Products

The company focuses on developing productsin 5 key areas of the Pharmaceuticals sector: Vaccines, Tuberculosis, HIV and hepatitis, haematology and insulin. In addition to this, the company has recently begun devlopment on a combined Flu and Coronavirus vaccine. ^[2]

Subsidiaries

-NGO "Microgen"

-"FORT"

-"Synthesis"

-MPO Metalist

The company also holds a 37% stake in Kirov Plasma.

References

^[1]

^[2]

[1] ttps://tadviser.com/index.php/Company:National_Immunobiology_Company_(Natsimbio)

[2] ttps://rostec.ru/en/news/the-human-stem-cell-institute-and-rostec-are-developing-influenza-and-covid-19-vaccine/

[3] ttps://rostec.ru/en/news/the-human-stem-cell-institute-and-rostec-are-developing-influenza-and-covid-19-vaccine/

[4] ttps://tadviser.com/index.php/Company:National_Immunobiology_Company_(Natsimbio)

[1]

[2]

[1]

[2]